| Active Not Recruiting | A Clinical Trial for Evaluation of Efficacy, Safety and Immunogenicity of GNR-127 (Recombinant ABP Antigen Pro Rhinitis, Allergic, Seasonal | Phase 1 / Phase 2 | 2024-10-07 |
| Active Not Recruiting | A Safety and Pharmacokinetics Study of Complarate (Tocilizumab Biosimilar Solution) and Actemra® in Healthy Vo Healthy Volunteers | Phase 1 | 2024-06-20 |
| Completed | An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Stil Still's Disease Adult Onset | Phase 3 | 2023-12-12 |
| Active Not Recruiting | An Efficacy and Safety Study of GNR-068 (Ustekinumab Biosimilar) and Stelara® in the Treatment of Patients Wit Plaque Psoriasis | Phase 3 | 2023-07-25 |
| Completed | A Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers Mucopolysaccharidosis Type II, Metabolic Diseases | Phase 1 | 2023-04-06 |
| Completed | Comparison of Complarate® (Tocilizumab Biosimilar) and Actemra® in Patients With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 3 | 2023-02-13 |
| Completed | A Study of Genolair in Two Dosage Forms (Solution and Lyophilisate) and Xolair® in Healthy Volunteers Allergic Asthma | Phase 1 | 2023-01-15 |
| Completed | A Safety, Pharmacokinetics and Pharmacodynamics Study of GNR-086 and Ilaris® in Healthy Volunteers Healthy Volunteers | Phase 1 | 2022-09-06 |
| Completed | A Safety and Pharmacokinetic Study of Complarate (Tocilizumab Biosimilar) and Actemra® in Healthy Volunteers Healthy Volunteers | Phase 1 | 2022-04-11 |
| Completed | Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients Idiopathic Thrombocytopenic Purpura | Phase 3 | 2022-03-28 |
| Unknown | Efficacy, Safety, pharmacokinetiсs, Immunogenicity of GNR-067 and Lucentis® Age Related Macular Degeneration (ARMD) | Phase 3 | 2022-03-20 |
| Completed | A Safety and Pharmacokinetics Study of Ustekinumab Biosimilar GNR-068 and Stelara® in Healthy Volunteers Healthy Volunteers | Phase 1 | 2022-03-11 |
| Withdrawn | Efficacy and Safety of GNR-038 vs Berinert® in Patients With Hereditary Angioedema Hereditary Angioedema | Phase 2 / Phase 3 | 2021-12-01 |
| Recruiting | A Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 in Patients With Mucopolysaccharidosis Type II Mucopolysaccharidosis Type II, Metabolic Diseases | Phase 2 / Phase 3 | 2021-11-30 |
| Completed | Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP Idiopathic Thrombocytopenic Purpura | Phase 3 | 2021-09-09 |
| Unknown | Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction ST Elevation Myocardial Infarction | Phase 3 | 2021-09-03 |
| Unknown | GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL B-precursor Acute Lymphoblastic Leukemia, ALL, GNR-084 | Phase 1 / Phase 2 | 2020-10-15 |
| Unknown | A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma | Phase 1 | 2020-07-22 |
| Completed | Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19 COVID-19, Coronavirus Disease 2019 | Phase 3 | 2020-06-01 |
| Completed | Safety and Pharmacokinetics of GNR-038 in Healthy Volunteers Hereditary Angioedema | Phase 1 | 2020-03-10 |
| Completed | A Multi-cohort Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers Mucopolysaccharidosis Type II, Metabolic Diseases | Phase 1 | 2020-02-28 |
| Completed | Observational Study of Elizaria® in aHUS Patients Atypical Hemolytic Uremic Syndrome, aHUS | — | 2019-12-19 |
| Completed | Prospective Observational Study of Long-term Pathogenic Treatment of Elizaria® Paroxysmal Nocturnal Hemoglobinuria | — | 2019-06-13 |
| Completed | An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial Asthma Bronchial Asthma | Phase 3 | 2018-06-20 |
| Completed | A Safety and Immunogenicity Study in Long-term Treatment of Eculizumab (JSC "GENERIUM", Russian Federation) Paroxysmal Nocturnal Hemoglobinuria | Phase 3 | 2018-05-03 |
| Completed | Efficacy and Safety of Elizaria® vs. Soliris® in Patients With PNH Paroxysmal Nocturnal Hemoglobinuria, Marchiafava-Micheli Syndrome, Paroxysmal Hemoglobinuria | Phase 3 | 2017-11-29 |
| Completed | Efficacy and Safety of Tigerase® vs. Pulmozyme® in Patients With Cystic Fibrosis Cystic Fibrosis, Fibrosis | Phase 3 | 2017-08-30 |
| Completed | Study of Pharmacokinetics, Pharmacodynamics and Safety Assessment of GNR-044 (JSC GENERIUM, Russia) and Xolair Healthy Volunteers | Phase 1 | 2017-04-18 |
| Completed | Efficacy and Safety Study of Proposed Biosimilar Product Reveliza vs Actilise in Patients With ST-segment Elev Myocardial Infarction (MI) | Phase 3 | 2014-05-25 |